Login
$CMTG
$1.18 -$0.04 (3.28%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Assets
Cash and cash equivalents
Restricted cash
Loan principal payments held by servicer
Loans receivable held-for-investment
Less: current expected credit loss reserve
Loans receivable held-for-investment, net
Loan receivable held-for-sale
Equity method investment
Real estate owned held-for-investment, net
Real Estate Owned Held-For-Sale
Other assets
Total assets
Liabilities and Equity
Repurchase agreements
Term participation facility
Loan participations sold, net
Notes payable, net
Secured term loan, net
Debt related to real estate owned hotel portfolio, net
Other liabilities
Dividends payable
Management fee payable - affiliate
Incentive fee payable - affiliate
Total liabilities
Equity
Common stock, $0.01 par value, 500,000,000 shares authorized, 141,084,206 and 140,218,764 shares issued and 141,084,206 and 140,218,764 shares outstanding at June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Total equity
Total liabilities and equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support